Display Settings:

Format

Send to:

Choose Destination
    Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7464-8.

    The carbohydrate domain of calicheamicin gamma I1 determines its sequence specificity for DNA cleavage.

    Source

    Department of Chemistry, Yale University, New Haven, CT 06511.

    Abstract

    We have investigated the DNA cleaving properties of calicheamicinone, the synthetic core aglycone of calicheamicin gamma I1, a natural product with extremely potent antitumor activity. Our experiments have shown that the synthetic analog binds and cleaves DNA, albeit without any sequence selectivity and with less efficiency than the natural compound. We propose that a key element in the sequence recognition process is the thiobenzoate ring present in the natural compound. We have demonstrated by one-dimensional NMR that there is direct hydrogen abstraction from DNA by calicheamicinone, with enhanced binding affinity contributed by the carbohydrate domain. The reduced efficiency of hydrogen abstraction from DNA by bound calicheamicinone, compared with the natural compound, implicates the carbohydrate moiety in positioning the drug for hydrogen abstraction.

    PMID:
    1881884
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC52320
    Free PMC Article

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk